首页> 外国专利> USE OF MULTILINEAGE DIFFERENTIATION STRESS-ENDURING CELL, DRUG FOR TREATING DIABETES AND PREPARATION METHOD THEREFOR

USE OF MULTILINEAGE DIFFERENTIATION STRESS-ENDURING CELL, DRUG FOR TREATING DIABETES AND PREPARATION METHOD THEREFOR

机译:使用多素分化胁迫 - 持续的细胞,用于治疗糖尿病的药物及其制备方法

摘要

Provided is the use of a multilineage differentiation stress-enduring cell in the preparation of a drug for treating diabetes. Also provided is a drug for treating diabetes. The drug at least comprises a cell suspension of the multilineage differentiation stress-enduring cell. The drug can also contain a pharmaceutically acceptable excipient. Further provided is a method for preparing a drug for treating diabetes, the method comprising the following steps: (1) preparing and culturing a multilineage differentiation stress-enduring cell; and (2) preparing a cell suspension of the multilineage differentiation stress-enduring cell.
机译:提供了在制备用于治疗糖尿病的药物中的多素分化胁迫性持久性细胞。还提供了一种治疗糖尿病的药物。该药物至少包含多线分化胁迫性持久性细胞的细胞悬浮液。该药物还可含有药学上可接受的赋形剂。进一步提供的是制备用于治疗糖尿病药物的方法,该方法包括以下步骤:(1)制备和培养多线分化胁迫性耐久性细胞; (2)制备多线粒分化胁迫终止细胞的细胞悬浮液。

著录项

  • 公开/公告号WO2021073042A1

    专利类型

  • 公开/公告日2021-04-22

    原文格式PDF

  • 申请/专利权人 NANTONG UNIVERSITY;

    申请/专利号WO2020CN80801

  • 申请日2020-03-24

  • 分类号A61K35/28;A61K9/10;A61K35/51;A61P25;A61P29;C12N5/0775;

  • 国家 CN

  • 入库时间 2022-08-24 18:22:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号